Page 33 - Martin Shkreli Case Study

Bibliography

1: gawker.com/

2: http://www.bloomberg.com/news/articles/2014-04-17/retrophins-martin-shkreli-the-
biotech-short-seller-who-went-long , accessed 15 Aug 2016
3: Wendy S. Armstrong, MD, FIDSA, FACP, medical director of the Ponce de
Leon Center in Atlanta and vice chair of HIVMA

4: ONE HUNDRED FOURTEENTH CONGRESS ELIJAH E. CUMMINGS,
MARYLAND
RANKING MINORITY MEMBER
COMMITTEE ON OVERSIGHT AND GOVERNMENT REFORM
2157 RAYBURN HOUSE OFFICE BUILDING WASHINGTON, DC
20515-6143
http://overstght.house.gov
MEMORANDUM February 2, 2016

5: http://www.bloomberg.com/news/articles/2015-09-25/old-drug-price-hike-
perversion-of-the-system-biogen-ceo-says

6: http://www.vanityfair.com/news/2015/12/martin-shkreli-pharmaceuticals-ceo-
interview

7. https://www.transcend.org/tms/2016/05/how-big-pharma-uses-charity-
programs-to-cover-for-drug-price-hikes/